AZ Spurns Pfizer Amd Bayer-Merck Deal Nears - Presented by: The Aol. On Network

It's already rejected one bid - now UK drugs maker AstraZeneca rejects a second. The improved £63 billion pound offer or £50 a share was made by U.S. rival Pfizer. There's still hope the deal will go ahead - making it the world's biggest pharmaceutical company. It would help boost Pfizer's pipeline of cancer drugs, cut its tax bill and create significant cost savings. But there are still obstacles to be overcome, says BGC's Mike Ingram.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
F $ 14.79 0.32 ▼ 2.12%
BAC $ 17.05 0.04 ▲ 0.24%
EBAY $ 56.63 3.97 ▲ 7.54%
AMD $ 3.41 0.14 ▼ 3.94%
PBR $ 14.19 0.51 ▼ 3.47%
AAPL $ 100.75 0.64 ▲ 0.64%
RAD $ 4.84 0.11 ▼ 2.22%
GE $ 25.62 0.20 ▲ 0.79%

As of 9/30/2014, 04:15 PM
More Most Active